Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
reverse merger
Biotech
Cash-strapped Quince finds salvation in reverse merger
Quince began seeking strategic alternatives after its lead candidate failed in a phase 3 trial for a rare pediatric neurodegenerative disease.
Darren Incorvaia
May 18, 2026 10:32am
Obsidian leverages Galera reverse merger to go public
Apr 14, 2026 11:20am
Alzheimer's-focused Korsana uses Cyclerion merger to go public
Apr 1, 2026 9:54am
Pulmatrix picked for reverse merger with anti-aging biotech
Mar 26, 2026 10:12am
Candid scores Nasdaq listing via reverse merger Rallybio
Mar 2, 2026 11:45am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
